As the US and beyond experience another wave of COVID-19, people with chronic diseases like multiple sclerosis and their health care providers continue to struggle to navigate the latest health guidance. In an effort to educate both communities, NeurologyLive^®, the Consortium of Multiple Sclerosis Centers (CMSC), and Can Do MS have produced a virtual summit where experts in immunology, virology, and neurology discuss infections and MS, the persistence of the SARS-CoV-2 virus, the impact of viral variants, the current vaccine landscape, and DMT guidance in a joint forum tailored for health care providers (HCP) as well as patients and caregivers.

Below, view recordings of both the HCP- and patient/caregiver-focused webinars.

*This program was originally broadcasted on August 24, 2021.

Healthcare Provider Perspective:

Speakers:

Kathy Costello, CRNP (Moderator), Vice President, Programs, Can Do Multiple Sclerosis; Amit Bar-Or, MD, FRCP, Director, Center for Neuroinflammation and Neurotherapeutics, Chief, Multiple Sclerosis Division at Penn Medicine; and Avindra Nath, MD, Intramural Clinical Director of the National Institute of Neurological Disorders and Stroke, The National Institutes of Health.

Patient/Caregiver Perspective:

Speakers:

Kathy Costello, CRNP (Moderator), Vice President of Programs, Can Do Multiple Sclerosis; Robert Shin, MD, professor of neurology and director, Georgetown Multiple Sclerosis and Neuroimmunology Center, Georgetown University; Nancy Sicotte, MD, Women’s Gild Distinguished Chair in Neurology Professor of Neurology and Director, Multiple Sclerosis and Neuroimmunology Program, Cedars-Sinai.